Reporting standards for chronic pancreatitis by using CT, MRI, and MR cholangiopancreatography: The consortium for the study of chronic pancreatitis, diabetes, and pancreatic cancer

Temel Tirkes, Zarine K. Shah, Naoki Takahashi, Joseph R. Grajo, Stephanie T. Chang, Sudhakar K. Venkatesh, Darwin L. Conwell, Evan Fogel, Walter Park, Mark Topazian, Dhiraj Yadav, Anil K. Dasyam

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Chronic pancreatitis is an inflammatory condition of the pancreas with clinical manifestations ranging from abdominal pain, acute pancreatitis, exocrine and/or endocrine dysfunction, and pancreatic cancer. There is a need for longitudinal studies in wellphenotyped patients to ascertain the utility of cross-sectional imaging findings of chronic pancreatitis for diagnosis and assessment of disease severity. CT and MR cholangiopancreatography are the most common cross-sectional imaging studies performed for the evaluation of chronic pancreatitis. Currently, there are no universal reporting standards for chronic pancreatitis. Several features of chronic pancreatitis are applied clinically, such as calcifications, parenchymal T1 signal changes, focal or diffuse gland atrophy, or irregular contour of the gland. Such findings have not been incorporated into standardized diagnostic criteria. There is also lack of consensus on quantification of disease severity in chronic pancreatitis, other than by using ductal features alone as described in the Cambridge classification. The Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC) was established by the National Institute of Diabetes and Digestive and Kidney Diseases and the National Cancer Institute in 2015 to undertake collaborative studies on chronic pancreatitis, diabetes mellitus, and pancreatic adenocarcinoma. CPDPC investigators from the Adult Chronic Pancreatitis Working Group were tasked with development of a new consensus approach to reporting features of chronic pancreatitis aimed to standardize diagnosis and assessment of disease severity for clinical trials. This consensus statement presents and defines features of chronic pancreatitis along with recommended reporting metrics.

Original languageEnglish (US)
Pages (from-to)207-215
Number of pages9
JournalRadiology
Volume290
Issue number1
DOIs
StatePublished - Jan 1 2019

Fingerprint

Chronic Pancreatitis
Pancreatic Neoplasms
National Institute of Diabetes and Digestive and Kidney Diseases (U.S.)
Endocrine Gland Neoplasms
National Cancer Institute (U.S.)
Pancreatitis
Abdominal Pain
Atrophy
Longitudinal Studies
Pancreas
Diabetes Mellitus
Adenocarcinoma
Cross-Sectional Studies
Research Personnel
Clinical Trials

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Reporting standards for chronic pancreatitis by using CT, MRI, and MR cholangiopancreatography : The consortium for the study of chronic pancreatitis, diabetes, and pancreatic cancer. / Tirkes, Temel; Shah, Zarine K.; Takahashi, Naoki; Grajo, Joseph R.; Chang, Stephanie T.; Venkatesh, Sudhakar K.; Conwell, Darwin L.; Fogel, Evan; Park, Walter; Topazian, Mark; Yadav, Dhiraj; Dasyam, Anil K.

In: Radiology, Vol. 290, No. 1, 01.01.2019, p. 207-215.

Research output: Contribution to journalArticle

Tirkes, Temel ; Shah, Zarine K. ; Takahashi, Naoki ; Grajo, Joseph R. ; Chang, Stephanie T. ; Venkatesh, Sudhakar K. ; Conwell, Darwin L. ; Fogel, Evan ; Park, Walter ; Topazian, Mark ; Yadav, Dhiraj ; Dasyam, Anil K. / Reporting standards for chronic pancreatitis by using CT, MRI, and MR cholangiopancreatography : The consortium for the study of chronic pancreatitis, diabetes, and pancreatic cancer. In: Radiology. 2019 ; Vol. 290, No. 1. pp. 207-215.
@article{f33d157c9f6b4def9ef3a5affcf2d8fb,
title = "Reporting standards for chronic pancreatitis by using CT, MRI, and MR cholangiopancreatography: The consortium for the study of chronic pancreatitis, diabetes, and pancreatic cancer",
abstract = "Chronic pancreatitis is an inflammatory condition of the pancreas with clinical manifestations ranging from abdominal pain, acute pancreatitis, exocrine and/or endocrine dysfunction, and pancreatic cancer. There is a need for longitudinal studies in wellphenotyped patients to ascertain the utility of cross-sectional imaging findings of chronic pancreatitis for diagnosis and assessment of disease severity. CT and MR cholangiopancreatography are the most common cross-sectional imaging studies performed for the evaluation of chronic pancreatitis. Currently, there are no universal reporting standards for chronic pancreatitis. Several features of chronic pancreatitis are applied clinically, such as calcifications, parenchymal T1 signal changes, focal or diffuse gland atrophy, or irregular contour of the gland. Such findings have not been incorporated into standardized diagnostic criteria. There is also lack of consensus on quantification of disease severity in chronic pancreatitis, other than by using ductal features alone as described in the Cambridge classification. The Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC) was established by the National Institute of Diabetes and Digestive and Kidney Diseases and the National Cancer Institute in 2015 to undertake collaborative studies on chronic pancreatitis, diabetes mellitus, and pancreatic adenocarcinoma. CPDPC investigators from the Adult Chronic Pancreatitis Working Group were tasked with development of a new consensus approach to reporting features of chronic pancreatitis aimed to standardize diagnosis and assessment of disease severity for clinical trials. This consensus statement presents and defines features of chronic pancreatitis along with recommended reporting metrics.",
author = "Temel Tirkes and Shah, {Zarine K.} and Naoki Takahashi and Grajo, {Joseph R.} and Chang, {Stephanie T.} and Venkatesh, {Sudhakar K.} and Conwell, {Darwin L.} and Evan Fogel and Walter Park and Mark Topazian and Dhiraj Yadav and Dasyam, {Anil K.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1148/radiol.2018181353",
language = "English (US)",
volume = "290",
pages = "207--215",
journal = "Radiology",
issn = "0033-8419",
publisher = "Radiological Society of North America Inc.",
number = "1",

}

TY - JOUR

T1 - Reporting standards for chronic pancreatitis by using CT, MRI, and MR cholangiopancreatography

T2 - The consortium for the study of chronic pancreatitis, diabetes, and pancreatic cancer

AU - Tirkes, Temel

AU - Shah, Zarine K.

AU - Takahashi, Naoki

AU - Grajo, Joseph R.

AU - Chang, Stephanie T.

AU - Venkatesh, Sudhakar K.

AU - Conwell, Darwin L.

AU - Fogel, Evan

AU - Park, Walter

AU - Topazian, Mark

AU - Yadav, Dhiraj

AU - Dasyam, Anil K.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Chronic pancreatitis is an inflammatory condition of the pancreas with clinical manifestations ranging from abdominal pain, acute pancreatitis, exocrine and/or endocrine dysfunction, and pancreatic cancer. There is a need for longitudinal studies in wellphenotyped patients to ascertain the utility of cross-sectional imaging findings of chronic pancreatitis for diagnosis and assessment of disease severity. CT and MR cholangiopancreatography are the most common cross-sectional imaging studies performed for the evaluation of chronic pancreatitis. Currently, there are no universal reporting standards for chronic pancreatitis. Several features of chronic pancreatitis are applied clinically, such as calcifications, parenchymal T1 signal changes, focal or diffuse gland atrophy, or irregular contour of the gland. Such findings have not been incorporated into standardized diagnostic criteria. There is also lack of consensus on quantification of disease severity in chronic pancreatitis, other than by using ductal features alone as described in the Cambridge classification. The Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC) was established by the National Institute of Diabetes and Digestive and Kidney Diseases and the National Cancer Institute in 2015 to undertake collaborative studies on chronic pancreatitis, diabetes mellitus, and pancreatic adenocarcinoma. CPDPC investigators from the Adult Chronic Pancreatitis Working Group were tasked with development of a new consensus approach to reporting features of chronic pancreatitis aimed to standardize diagnosis and assessment of disease severity for clinical trials. This consensus statement presents and defines features of chronic pancreatitis along with recommended reporting metrics.

AB - Chronic pancreatitis is an inflammatory condition of the pancreas with clinical manifestations ranging from abdominal pain, acute pancreatitis, exocrine and/or endocrine dysfunction, and pancreatic cancer. There is a need for longitudinal studies in wellphenotyped patients to ascertain the utility of cross-sectional imaging findings of chronic pancreatitis for diagnosis and assessment of disease severity. CT and MR cholangiopancreatography are the most common cross-sectional imaging studies performed for the evaluation of chronic pancreatitis. Currently, there are no universal reporting standards for chronic pancreatitis. Several features of chronic pancreatitis are applied clinically, such as calcifications, parenchymal T1 signal changes, focal or diffuse gland atrophy, or irregular contour of the gland. Such findings have not been incorporated into standardized diagnostic criteria. There is also lack of consensus on quantification of disease severity in chronic pancreatitis, other than by using ductal features alone as described in the Cambridge classification. The Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC) was established by the National Institute of Diabetes and Digestive and Kidney Diseases and the National Cancer Institute in 2015 to undertake collaborative studies on chronic pancreatitis, diabetes mellitus, and pancreatic adenocarcinoma. CPDPC investigators from the Adult Chronic Pancreatitis Working Group were tasked with development of a new consensus approach to reporting features of chronic pancreatitis aimed to standardize diagnosis and assessment of disease severity for clinical trials. This consensus statement presents and defines features of chronic pancreatitis along with recommended reporting metrics.

UR - http://www.scopus.com/inward/record.url?scp=85058895948&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058895948&partnerID=8YFLogxK

U2 - 10.1148/radiol.2018181353

DO - 10.1148/radiol.2018181353

M3 - Article

C2 - 30325281

AN - SCOPUS:85058895948

VL - 290

SP - 207

EP - 215

JO - Radiology

JF - Radiology

SN - 0033-8419

IS - 1

ER -